awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38958120-1B8FDAAB-8E64-4E40-BCF5-42DFC06ECF40
Q38958120-1B8FDAAB-8E64-4E40-BCF5-42DFC06ECF40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38958120-1B8FDAAB-8E64-4E40-BCF5-42DFC06ECF40
Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury.
P2860
Q38958120-1B8FDAAB-8E64-4E40-BCF5-42DFC06ECF40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38958120-1B8FDAAB-8E64-4E40-BCF5-42DFC06ECF40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
302daeec5e11ffcc32db39f11040c1e87339cdb8
P2860
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial.